Aug 2026· ChemBioChem· Vol 27 17, pp.
e70525
· 0 citations· 111 references
Medicine
TL;DR
This review systematically summarizes the design and key technological advances in peptide aptamers, emphasizing both traditional experimental screening and computer-aided design strategies, and highlights representative applications of peptide aptamers in pathogen detection, providing a reference for developing high-performance recognition elements and novel detection platforms.
Abstract
Peptide aptamers are short synthetic peptides that recognize targets with high affinity and specificity, offering advantages over antibodies and nucleic acid aptamers in size, structural flexibility, biocompatibility, and ease of chemical modification. Their design has progressed from traditional experimental screening to advanced computational approaches, such as structure-based rational design and artificial intelligence-driven generation. These methods have substantially enhanced screening efficiency and binding performance. For pathogen detection, biosensors employing peptide aptamers enable the rapid, sensitive, and specific identification of viruses, parasites, and other pathogens. Although challenges in affinity and stability remain, ongoing innovation positions peptide aptamers as a promising molecular tool for next-generation diagnostic platforms. This review systematically summarizes the design and key technological advances in peptide aptamers, emphasizing both traditional experimental screening and computer-aided design strategies. It also highlights representative applications of peptide aptamers in pathogen detection, providing a reference for developing high-performance recognition elements and novel detection platforms.
The emerging role of aptamer-based biosensors (aptasensors) as innovative alternatives for malaria detection are examined, demonstrating the potential of aptasensors to enable highly sensitive, selective, and portable point-of-care diagnostics for malaria surveillance and management.
J. Centelles, Santiago Imperial· Biosensors· 0 citations
Peptide phage display is a cornerstone technology in molecular engineering, providing a robust platform for the rapid discovery of high-affinity ligands. The rapid rise of peptides, especially in therapeutics, over recent years has shed light on the importance of phage display as a tool for peptide discovery. The evolu...
Belle Li Ling, Huan Peng, T. S. Lim· Biotechnology and Bioenginee...· 0 citations
Since the advent of systematic evolution of ligands by exponential enrichment (SELEX), numerous protein-binding aptamers have been reported, yet their binding characterizations are often less developed than those of small-molecule aptamers, limiting mechanistic understanding and practical applications. Here, we establi...
Nucleic acid aptamers, often referred to as “chemical antibodies,” are versatile, specific, and easily modifiable functional nucleic acids. There is a growing focus on new methods for the selection and target validation of aptamers, with the aim of expanding their biomedical applications in molecular diagnostics and th...
Ding-Kun Ji, Hao-Zhi Lei, Jia Liu et al.· Signal Transduction and Targ...· 0 citations
Aptamers—short, single‐stranded nucleic acids capable of folding into complex three‐dimensional structures—have evolved from biochemical curiosities into programmable molecular interfaces with expanding diagnostic and therapeutic relevance. Through systematic evolution of ligands by exponential enrichment (SELEX), apta...
Arshad Mehmood, Miraj Ud Din, S. K. Shah et al.· The FASEB Journal· 0 citations
A high-throughput aptamer engineering platform that combines a random-rational hybrid library diversification with repurposed MiSeq screening to rapidly reprogram aptamers against emerging SARS-CoV-2 spike variants is demonstrated, demonstrating a rapid and sequence-resolved aptamer engineering platform for adapting ap...
Yu-Jie He, Zhenglin Yang, Yu-An Kuo et al.· ACS Nano· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.